Traws Pharma Stockholders Approve 2M Share Incentive Plan Increase

Key Highlights

• Stockholders approved an amendment to the 2021 Incentive Compensation Plan.
• The amendment increases shares available for issuance by 2,000,000.
• Seven directors were elected to hold office until the 2027 Annual Meeting.
• KPMG LLP was ratified as the independent registered public accounting firm for 2026.
• Approved the issuance of common stock upon exercise of Series B and C Warrants.
• The Incentive Plan amendment was approved with 4,821,796 votes For.
• The warrant issuance was approved with 2,270,414 votes For.
• A quorum was present with 55.78% of outstanding shares represented at the meeting.